These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 994508

  • 1. Combination chemotherapy in the treatment of advanced breast cancer.
    Rosner D, Nemoto T, Dao TL.
    J Surg Oncol; 1976; 8(6):465-9. PubMed ID: 994508
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combination chemotherapy for disseminated carcinoma of the breast.
    Lozada JA, Grillo-López A, Vélez-Garciá E.
    Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588
    [No Abstract] [Full Text] [Related]

  • 4. Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.
    Muss HB, White DR, Cooper MR, Richards F, Spurr CL.
    Arch Intern Med; 1977 Dec; 137(12):1711-4. PubMed ID: 337916
    [Abstract] [Full Text] [Related]

  • 5. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
    Mouridsen HT, Palshof T, Brahm M, Rahbek I.
    Ugeskr Laeger; 1977 Oct 31; 139(44):2632-5. PubMed ID: 929742
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
    Smalley RV, Murphy S, Huguley CM, Bartolucci AA.
    Cancer Res; 1976 Nov 31; 36(11 Pt 1):3911-6. PubMed ID: 975039
    [Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy for metastatic breast cancer: comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy.
    Nemoto T, Rosner D, Diaz R, Dao T, Sponzo R, Cunningham T, Horton J, Simon R.
    Cancer; 1978 Jun 31; 41(6):2073-7. PubMed ID: 657080
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Five-drug therapy in advanced breast cancer: factors influencing toxicity and response.
    Davis HL, Ramirez G, Ellerby RA, Ansfield FJ.
    Cancer; 1974 Aug 31; 34(2):239-45. PubMed ID: 4852055
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity.
    Hirshaut Y, Kesselheim H.
    Cancer; 1983 Jun 01; 51(11):1998-2004. PubMed ID: 6687698
    [Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study.
    Hoogstraten B, George SL, Samal B, Rivkin SE, Costanzi JJ, Bonnet JD, Thigpen T, Braine H.
    Cancer; 1976 Jul 01; 38(1):13-20. PubMed ID: 947510
    [Abstract] [Full Text] [Related]

  • 16. Combination chemotherapy in disseminated carcinoma of the breast.
    Stutz FH, Blom J, Tormey DC.
    Oncology; 1974 Jul 01; 29(2):139-46. PubMed ID: 4525917
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.